By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Ramsey  New Jersey    U.S.A.
Phone: Fax:



Start Up

Company News
Valeritas Completes Alternative Public Offering And Raises Gross Proceeds Of $25.2 Million 5/4/2016 6:49:11 AM
Peter J. Devlin Joins Valeritas Board Of Directors As Independent Director 4/25/2016 9:22:42 AM
Valeritas Wins Silver Medal And Announces Positive Results Of Two Retrospective Study Analyses Of The V-Go Disposable Insulin Delivery Device In Poster Presentations At AMCP 4/22/2016 6:37:10 AM
Rodney D. Altman, MD Joins Valeritas Board Of Directors 4/19/2016 10:45:41 AM
Valeritas Officially Shelves $75 MIllion IPO 3/11/2016 7:12:10 AM
Insulin Delivery With Valeritas' V-Go Disposable Insulin Delivery Device Demonstrated Greater Glycemic Control, Less Insulin Utilization And Cost Effectiveness When Compared To Subcutaneous Multiple Daily Insulin Injections 2/16/2016 9:22:14 AM
Valeritas’ V-Go Device Shows To Help Improve Compliance And Efficacy For Patients With Diabetes On Insulin + GLP-1 Therapy As Well As Those Who Switched From Subcutaneous Insulin Injections To V-Go 10/23/2015 10:34:44 AM
Valeritas’ V-Go Disposable Insulin Delivery Device Demonstrates Efficacy And Safety In Patients With Diabetes 10/22/2015 9:32:28 AM
Real-World Study Data Demonstrating That Valeritas' V-Go Consistently Reduces A1C Levels And Decreases Insulin Requirements For Patients With Diabetes Regardless Of Baseline A1C Presented At American Diabetes Association 2015 6/8/2015 9:13:19 AM
Real-World Data From Three Separate Studies Demonstrate That Valeritas' V-Go Significantly Reduces A1c And Lowers Total Daily Insulin Dose For Patients With Diabetes 5/18/2015 10:25:11 AM